Lorne Genome: Gaps in the genome
22 March, 2005 by Melissa TrudingerMelissa Trudinger takes a candid look at the state of genomics research in Australia.
Lorne Genome: True blue genomics
22 March, 2005 by Melissa TrudingerAcross the Australian research landscape, small genome projects are pushing their heads above the ground.
Lorne Genome: O Canada! Can we copy your example?
22 March, 2005 by Melissa TrudingerCanada was one of the first countries to hop on the genomics bandwagon after the human genome project was completed. Since 2001, the Canadian federal government has invested C$386 million into Genome Canada, an independently operated organisation with the role of coordinating and funding genomics and proteomics research across Canada.
Proteome snags grant for TB test
17 March, 2005 by Graeme O'NeillSydney's Proteome Systems has won a US$2 million federal government R&D Start grant to advance development of its new rapid diagnostic for tuberculosis.
Nanyang invests $2.5m in Genetic Solutions
17 March, 2005 by Graeme O'NeillSydney venture capital company Nanyang Ventures has injected $2.5 million into Genetic Solutions to help accelerate the Brisbane genetic information-technology company's product development and international marketing initiatives.
Nucleonics responds to criticisms of new patents
14 March, 2005 by Graeme O'NeillRNA-interference therapeutics company Nucleonics has disputed claims by Queensland rival Benitec (ASX:BTL) that two new Australian patents on RNAi technology granted to the Medical College of Georgia Research Institute are "largely irrelevant" to companies involved in medical applications of RNAi.
Nucleonics granted two RNAi patents by IP Australia
10 March, 2005 by Graeme O'NeillRNA-interference therapeutics company Nucleonics has announced that IP Australia has granted the Medical College of Georgia Research Institute (MCGRI) two patents covering an RNAi gene-silencing technique. Nucleonics is a licensee to both patents.
Gene chip could save dairy industry big bucks
04 March, 2005 by Graeme O'NeillMastitis, or bacterial infections of the udder, is a AUD$140 million a year problem for Australia's dairy industry. It can cost farmers up to $150 an animal to treat, and affects both milk output and quality.
Sydney researchers identify bipolar gene
02 March, 2005 by Graeme O'NeillResearchers at Sydney's Garvan Institute have identified a gene coding for a cell-adhesion molecule in the brain as a strong risk factor for bipolar disorder, or manic depression.
Gribbles and Sequenom team up on genetic diagnostics
28 February, 2005 by Susan WilliamsonA new collaboration between Gribbles Molecular Science and Sequenom may pave the way for diagnostics which link pathology expertise with genetics, and could have applications in personalised medicine and foresenic identification.
Genentech and the sonic hedgehog
28 February, 2005 by Graeme O'NeillDecades ago, ranchers who moved their sheep up to the high-altitude summer pastures of the Californian Sierra found lambs were being stillborn with gross deformities, including a distorted skull with a single eye, a forebrain with the hemispheres are fused into a single mass, and lacking a medulla, a collapsed chest without lungs, and a long proboscis-like nose.
Proteome to keep close eye on the bottom line
25 February, 2005 by Renate KrelleProteome Systems (ASX:PXL) has reported a half-year loss before tax of AUD$14.2 million, and with cash of only $11.6 million at December 31. the company is watching its pennies extremely carefully.
Melbourne scientist finds gene that makes a man a man
22 February, 2005 by Graeme O'NeillWhen it was cloned in 1991, the sex-determining region, Y-chromosome (SRY) gene was hailed as the elusive 'master switch' that sets an genetically male embryo on the path to male development. But it is now clear that SRY is just the finger that flicks the real switch to 'male'. It's the transcription factor gene SOX9 that causes the embryo's indeterminate gonads to develop as testes, not ovaries
'Inebriomics' taps genetics of alcoholism
21 February, 2005 by Graeme O'NeillTiny nematode worms that get 'legless' more rapidly than their peers when they ingest alcohol have led a San Franciso team to the gene that is the major determinant of susceptibility to alcoholism in worms -- and probably in humans as well.
BresaGen licenses protein production tech
17 February, 2005 by Melissa TrudingerBresaGen (ASX:BGN) has obtained a non-exclusive license enabling technology from the Massachusetts Institute of Technology for the production of proteins and peptides in bacteria.
